Replimune axes CMO role and CMO Pirzkall along with it

Andrea Pirzkall, M.D., had been the biotech’s CMO since July 2020, but, just over a year into the job, Replimune, which focuses on cancer-killing viruses, says it no longer needs the CMO role at all.

In a Securities and Exchange Commission filing, the biotech said it “has restructured the company’s management and operations such that all functions previously reporting to the Chief Medical Officer now report directly to the President and Chief Research and Development Officer, Dr. Robert Coffin or the Chief Development Operations Officer, Tanya Lewis.